Gavi, Girl Effect Launch Partnership To Increase HPV Vaccine Demand In 3 African Nations

The Guardian: $10m campaign targets cervical cancer among girls in sub-Saharan Africa
“A partnership worth $10m (£8.1m) to increase the uptake and awareness of a vaccine to protect girls from cervical cancer, which has higher death rates in sub-Saharan Africa than any other cancer, was launched on Tuesday. Gavi, the Vaccine Alliance, announced it is joining forces with the Girl Effect to increase the demand for the human papillomavirus (HPV) vaccine in Rwanda, Ethiopia, and Malawi…” (Ford, 10/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.